Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared on X:
Authors: A. Sobrero, L. Isa, E. Cortesi, S. Barni, D. Nicolella, M. Aglietta, S. Lonardi, D. Corsi, D. Turci, G.D. Beretta, G. Fornarini, E. Dapretto, I. Floriani, A. Zaniboni.
Intermittent FOLFIRI given on a 2 month on-off schedule doesn’t compromise PFS and OS in advanced colon cancer.”